US 5,225,184 A · Medicaments

Abstract

The present invention relates to the treatment and prophylaxis of Pneumocystis carinii infections with 2-[4-(4-chlorophenyl)cyclohexyl-3-hydroxy-1,4-naphthoquinone.

Claims2

Dependent claims

An aerosol container containing an effective Pneumocystis Carinii treatment amount of a micronized trans compound of formula (II) ##STR3## or a physiologically acceptable salt thereof suspended in an aerosol propellant therefor.

Dependencies are inferred from the claim text.

Facts

Application

07/619,880Filed 29 Nov 1990 · division

Priority

15 Aug 1989

Granted

6 Jul 1993

Term ends

Not estimatedThe source records don’t support an estimate.

Classification13 codes

C07C 229/60
With amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring: with amino and carboxyl groups bound in…
A61K 31/12
Medicinal preparations containing organic active ingredients: ketones
C07C 46/00
Preparation of quinones
C07C 50/24
Quinones: containing halogen

Abstract

The present invention relates to the treatment and prophylaxis of Pneumocystis carinii infections with 2-[4-(4-chlorophenyl)cyclohexyl-3-hydroxy-1,4-naphthoquinone.

Medicaments

Life of this patent

Abstract

Claims2

Medicaments

Life of this patent

Abstract

Claims2